Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Journal of Neurosurgery

• Publication date

  1978-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3171/JNS.1978.49.3.0333PMID 355604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic factors for patients with brain tumors.

  1977cited by this paper
• Evaluation of mithramycin in the treatment of anaplastic gliomas.

  1976cited by this paper
• A pharmacologic basis for brain tumor chemotherapy.

  1975cited by this paper
• A pharmacologic basis for brain tumor chemotherapy.

  1975cited by this paper
• Glioblastoma multiforme—A review of therapy

  1974cited by this paper
• Tumors of the central nervous system

  1972cited by this paper
• BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.

  1970cited by this paper
• 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.

  1970cited by this paper
• The treatment of glioblastoma multiforme of the brain.

  1967cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. VII.

  1964cited by this paper
• Evaluation of antileukemic agents employing advanced leukemia L-1210 in mice. V.

  1964cited by this paper
• Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia.

  1963cited by this paper
• Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment.

  1958cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Triethylene melamine in the treatment of neoplastic disease.

  1952cited by this paper
• Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

  1951cited by this paper

• Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.

  2026cites this paper
• A regulatory biomimetic nanoparticle targeting senescent glioma cells for BNCT treatment

  2026cites this paper
• The functional imperative in high-grade glioma

  2026cites this paper
• Innovative radiotherapies for the treatment of glioblastoma

  2025cites this paper
• Radiotherapeutic approaches in the treatment of adult gliomas.

  2025cites this paper
• Comparison of Quality of Life in Postoperative High-Grade Glioma Patients Treated Using EORTC and RTOG Target Delineation Techniques for Postoperative Radiotherapy

  2025cites this paper
• The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management

  2025cites this paper
• Use of radiofrequency electromagnetic fields applied by capacitive hyperthermia for glioblastoma therapy

  2025cites this paper
• Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future.

  2025cites this paper
• Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma

  2025influential citation
• Amino Acid Deprivation in Glioblastoma: The Role in Survival and the Tumour Microenvironment—A Narrative Review

  2024cites this paper
• A systematic review of normal tissue neurovascular unit damage following brain irradiation—Factors affecting damage severity and timing of effects

  2024cites this paper
• Targeted Glioma Therapy—Clinical Trials and Future Directions

  2024cites this paper
• Local delivery of carboplatin-loaded hydrogel and calcium carbonate enables two-stage drug release for limited-dose radiation to eliminate mouse malignant glioma.

  2024cites this paper
• Current status of precision oncology in adult glioblastoma

  2024cites this paper
• Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapy.

  2024cites this paper
• Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma

  2024cites this paper
• PC12 Cell Conditional Medium Prepared after Latroeggtoxin-VI Treatment Suppresses Glioma Cells

  2024cites this paper
• Bilateral thalamic high‐grade astrocytomas in an early‐adolescent child: A case report

  2024cites this paper
• In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma

  2024cites this paper
• Lipidomics-driven drug discovery and delivery strategies in glioblastoma.

  2024cites this paper
• Strategies to Improve Drug Delivery Across the Blood–Brain Barrier for Glioblastoma

  2024cites this paper
• Prognostic Value of Apparent Diffusion Coefficient (ADC) in Patients with Diffuse Gliomas

  2024cites this paper
• Comparison of different target volume delineation strategies based on recurrence patterns in adjuvant radiotherapy for glioblastoma

  2024cites this paper
• Targeting drug resistance in glioblastoma (Review)

  2024cites this paper
• Practical Nomograms and Risk Stratification System for Predicting the Overall and Cancer-specific Survival in Patients with Anaplastic Astrocytoma.

  2024cites this paper
• Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies.

  2024cites this paper
• Prediction of prognosis in glioblastoma with radiomics features extracted by synthetic MRI images using cycle-consistent GAN

  2024cites this paper
• Sleep disorders associated with cranial radiation - a systematic review.

  2024cites this paper
• Neoadjuvant Clinical Trials in Adults with Newly Diagnosed High-Grade Glioma: A Systematic Review.

  2024cites this paper
• Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients with Primary Anaplastic Oligodendroglioma.

  2024cites this paper
• Radiosensitization of IDH-mutated Gliomas through ZMYND8 - a Pathway to Improved Outcomes.

  2023cites this paper
• Impact of age and gender on glioblastoma onset, progression, and management.

  2023cites this paper
• Early Gamma Knife Therapy (Without EBRT) in Operated Patients of Glioblastoma Multiforme

  2023cites this paper
• Hypofractionated radiotherapy of patients with glioblastoma: the first experience in Ukraine and prospects view

  2023cites this paper
• Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance

  2023cites this paper
• Anti-epileptic drug use during adjuvant chemo-radiotherapy is associated with poorer survival in patients with glioblastoma: A nationwide population-based cohort study.

  2023cites this paper
• Proton beam therapy for gliomas: a multicenter prospective registry study from all proton beam facilities in Japan

  2023cites this paper
• Role of Oxidative Stress in Metabolic Reprogramming of Brain Cancer

  2023cites this paper
• Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis

  2023cites this paper
• Role of Radiotherapy in High Grade Glioma

  2023cites this paper
• Aspects of hypofractionation in modern radiation oncology

  2023cites this paper
• The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study

  2023cites this paper
• Personalized Treatment of Glioblastoma: Current State and Future Perspective

  2023cites this paper
• Malignant Glioma.

  2023cites this paper
• Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery.

  2023cites this paper
• Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme

  2023cites this paper
• Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial

  2023cites this paper
• Gene Therapy for High Grade Glioma: The Clinical Experience

  2022cites this paper
• Central Nervous System Tumors

  2022cites this paper
• Survival analysis in high-grade glioma: The role of salvage surgery.

  2022cites this paper
• Harnessing Ultrasound for Targeting Drug Delivery to the Brain and Breaching the Blood–Brain Tumour Barrier

  2022cites this paper
• Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration

  2022cites this paper
• Consenso sobre guías de tratamiento de gliomas de bajo grado elaborado por el grupo de tumores de la SENEC

  2022cites this paper
• Application of Biomaterials for Glioblastoma Treatment: Promises, Advances, and Challenges

  2022cites this paper
• Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients.

  2022cites this paper
• Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.

  2022cites this paper
• A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma (GBM)

  2022cites this paper
• Advanced MRI Protocols to Discriminate Glioma From Treatment Effects: State of the Art and Future Directions

  2022cites this paper
• Preoperative Stereotactic Radiosurgery for Glioblastoma

  2022cites this paper
• Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research

  2022cites this paper
• High-grade gliomas: a literature review. Part 2. Radiosurgical treatment

  2022cites this paper
• Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient‐level data from 4 prospective trials

  2022cites this paper
• Neurosurgery's Impact on Neuro-Oncology-"Can We Do Better?"-Lessons Learned Over 50 Years.

  2022cites this paper
• Cytochrome c oxidase mediates labile iron level and radioresistance in glioblastoma.

  2022cites this paper
• Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma

  2022cites this paper
• High grade gliomas.

  2022cites this paper
• Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy

  2022cites this paper
• Gliomas: Genetic alterations, mechanisms of metastasis, recurrence, drug resistance, and recent trends in molecular therapeutic options.

  2022cites this paper
• Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not.

  2022cites this paper
• Principles of Radiation Therapy for Glioblastoma Patients

  2021cites this paper
• Immunotherapy for glioblastoma as a means to overcome resistance to standard therapy

  2021cites this paper
• Investigational new drugs against glioblastoma

  2021cites this paper
• The prognostic factors and nomogram for patients with high-grade gliomas

  2021cites this paper
• The Role of Delayed Radiotherapy Initiation in Patients with Newly Diagnosed Glioblastoma with Residual Tumor Mass

  2021cites this paper
• Radiation Therapy for Grade 3 Gliomas: Correlation of MRI Findings With Prognosis

  2021cites this paper
• Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost

  2021cites this paper
• Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)

  2021cites this paper
• Viability fingerprint of glioblastoma cell lines: roles of mitotic, proliferative, and epigenetic targets

  2021cites this paper
• Letter: Is the Stupp Protocol an Expensive and Unsustainable Standard of Care for Glioblastoma in Low- and Middle-Income Country Settings? A Call to Action!

  2021cites this paper
• Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma

  2021cites this paper
• Adjuvant Temozolomide for the Treatment of Glioblastoma: A Meta-analysis of Randomized Controlled Studies

  2021cites this paper
• Immune Cell Infiltration Score and Predicting Model Among Lower-grade Gliomas Based on Immunogenomic Clusters

  2021cites this paper
• Novel Radiation Approaches.

  2021cites this paper
• Evidence of Reelin Signaling in GBM and Its Derived Cancer Stem Cells

  2021cites this paper
• A New Era of Neuro-Oncology Research Pioneered by Multi-Omics Analysis and Machine Learning

  2021cites this paper
• Exploring the Pivotal Neurophysiologic and Therapeutic Potentials of Vitamin C in Glioma

  2021cites this paper
• Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.

  2021cites this paper
• Historical perspective on surgery and survival with glioblastoma: how far have we come?

  2021cites this paper
• Current FDA-Approved Therapies for High-Grade Malignant Gliomas

  2021cites this paper
• Extracellular Matrix Proteins Confer Cell Adhesion-Mediated Drug Resistance Through Integrin αv in Glioblastoma Cells

  2021cites this paper
• Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol

  2021cites this paper
• Contribution of intraoperative stimulation mapping to glioblastoma surgery within or adjacent to descending motor pathways: survival analysis and functional outcome comparison between two series in a single institution

  2021cites this paper
• Dandy's hemispherectomies: historical vignette.

  2021cites this paper
• Our Experience in using the Novo-TTF 100A System for the Treatment of Glioblastoma

  2021cites this paper
• Initial results of a phase II trial of 18F-DOPA PET-guided dose-escalated radiotherapy for glioblastoma.

  2021cites this paper
• Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model

  2021cites this paper
• Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center

  2021cites this paper
• Differential genes and scoring criteria among immunogenomic clusters of lower-grade gliomas.

  2021cites this paper
• From 65 to 70 years old: what is the best approach in the treatment of glioblastoma?

  2021cites this paper